Effect of intraperitoneal chemotherapy concentration on morbidity and survival.

Fortuné M K ElekonawoW J van EdenW Y van der PlasR S G EwaldsL A W de JongA J A BremersP H J HemmerN F M KokS KruijffA G J AalbersP R de Reuver

Published in: BJS open (2020)

CRS-HIPEC was performed with a wide variation in intraperitoneal chemotherapy concentrations that were not associated with complications or survival.

Keyphrases